Zydus Cadila gets USFDA nod to market generic drug

The company has received approval from the US Food and Drug Administration (USFDA) to market in the US its generic version in strengths of 1 mg, 2.5 mg, 5 mg, and 10 mg, Zydus Cadila said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3yVwlhl
via IFTTT